• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响噬菌体稳定性/活性的因素:噬菌体实际应用中的挑战。

Factors determining phage stability/activity: challenges in practical phage application.

机构信息

a Bacteriophage Laboratory, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences , Wroclaw , Poland.

b Department of Clinical Immunology, Transplantation Institute, Medical University of Warsaw , Warsaw , Poland.

出版信息

Expert Rev Anti Infect Ther. 2019 Aug;17(8):583-606. doi: 10.1080/14787210.2019.1646126. Epub 2019 Jul 24.

DOI:10.1080/14787210.2019.1646126
PMID:31322022
Abstract

: Phages consist of nucleic acids and proteins that may lose their activity under different physico-chemical conditions. The production process of phage formulations may decrease phage infectivity. Ingredients present in the preparation may influence phage particles, although preparation and storage conditions may also cause variations in phage titer. Significant factors are the manner of phage application, the patient's immune system status, the type of medication being taken, and diet. : We discuss factors determining phage activity and stability, which is relevant for the preparation and application of phage formulations with the highest therapeutic efficacy. Our article should be helpful for more insightful implementation of clinical trials, which could pave the way for successful phage therapy. : The number of naturally occurring phages is practically unlimited and phages vary in their susceptibility to external factors. Modern methods offer engineering techniques which should lead to enhanced precision in phage delivery and anti-bacterial activity. Recent data suggesting that phages may also be used in treating nonbacterial infections as well as anti-inflammatory and immunomodulatory agents add further weight to such studies. It may be anticipated that different phage activities could have varying susceptibility to factors determining their actions.

摘要

噬菌体由核酸和蛋白质组成,在不同的理化条件下可能失去活性。噬菌体制剂的生产过程可能会降低噬菌体的感染力。制剂中存在的成分可能会影响噬菌体颗粒,尽管制剂和储存条件也可能导致噬菌体效价发生变化。重要的因素是噬菌体的应用方式、患者的免疫系统状况、所服用的药物类型和饮食。

我们讨论了决定噬菌体活性和稳定性的因素,这对于制备和应用具有最高治疗效果的噬菌体制剂至关重要。我们的文章应该有助于更深入地实施临床试验,为噬菌体治疗的成功铺平道路。

自然界中存在的噬菌体数量实际上是无限的,而且噬菌体对外界因素的敏感性也各不相同。现代方法提供了工程技术,这应该有助于提高噬菌体传递和抗菌活性的精度。最近的数据表明,噬菌体也可以用于治疗非细菌性感染以及抗炎和免疫调节药物,这进一步支持了此类研究。可以预期,不同的噬菌体活性可能对决定其作用的因素有不同的敏感性。

相似文献

1
Factors determining phage stability/activity: challenges in practical phage application.影响噬菌体稳定性/活性的因素:噬菌体实际应用中的挑战。
Expert Rev Anti Infect Ther. 2019 Aug;17(8):583-606. doi: 10.1080/14787210.2019.1646126. Epub 2019 Jul 24.
2
Formulation, stabilisation and encapsulation of bacteriophage for phage therapy.噬菌体的制剂学、稳定性和包封用于噬菌体治疗。
Adv Colloid Interface Sci. 2017 Nov;249:100-133. doi: 10.1016/j.cis.2017.05.014. Epub 2017 May 14.
3
Phage Therapy Approaches to Reducing Pathogen Persistence and Transmission in Animal Production Environments: Opportunities and Challenges.噬菌体疗法在减少动物生产环境中病原体持续存在和传播方面的应用:机遇与挑战。
Microbiol Spectr. 2017 Jun;5(3). doi: 10.1128/microbiolspec.PFS-0017-2017.
4
Applications of bacteriophages versus phage enzymes to combat and cure bacterial infections: an ambitious and also a realistic application?噬菌体及其酶在治疗细菌感染中的应用:一个雄心勃勃且现实的应用?
Appl Microbiol Biotechnol. 2018 Mar;102(6):2563-2581. doi: 10.1007/s00253-018-8811-1. Epub 2018 Feb 13.
5
Bacteriophages and its applications: an overview.噬菌体及其应用:综述。
Folia Microbiol (Praha). 2017 Jan;62(1):17-55. doi: 10.1007/s12223-016-0471-x. Epub 2016 Oct 8.
6
Bacteriophages and their derivatives for the treatment and control of food-producing animal infections.用于治疗和控制食用动物感染的噬菌体及其衍生物。
Crit Rev Microbiol. 2017 Sep;43(5):583-601. doi: 10.1080/1040841X.2016.1271309. Epub 2017 Jan 10.
7
Towards Inhaled Phage Therapy in Western Europe.迈向西欧的吸入噬菌体疗法。
Viruses. 2019 Mar 23;11(3):295. doi: 10.3390/v11030295.
8
Stability of magistral phage preparations before therapeutic application in patients with chronic rhinosinusitis, sepsis, pulmonary, and musculoskeletal infections.在治疗慢性鼻-鼻窦炎、脓毒症、肺部和肌肉骨骼感染患者之前,制剂的噬菌体制剂的稳定性。
Microbiol Spectr. 2023 Dec 12;11(6):e0290723. doi: 10.1128/spectrum.02907-23. Epub 2023 Oct 11.
9
[Phage therapy, an alternative to antibiotic therapy?)].[噬菌体疗法,抗生素疗法的替代方案?]
Rev Esp Quimioter. 2018 Apr;31(2):101-104. Epub 2018 Feb 16.
10
[Bacteriophages in the battle against multidrug resistant bacteria].[噬菌体在对抗多重耐药细菌的战斗中]
Ned Tijdschr Geneeskd. 2018;162:D2433.

引用本文的文献

1
Expanding structural insights into DNA packaging apparatus and endolysin LysSA05 function of Epsilon15 bacteriophage.拓展对Epsilon15噬菌体DNA包装装置和内溶素LysSA05功能的结构认识。
Front Cell Infect Microbiol. 2025 Aug 14;15:1643576. doi: 10.3389/fcimb.2025.1643576. eCollection 2025.
2
Nanocoated bacterial carriers enhance oral bacteriophage delivery efficiency.纳米涂层细菌载体提高口服噬菌体递送效率。
Acta Pharm Sin B. 2025 Aug;15(8):4319-4321. doi: 10.1016/j.apsb.2025.05.037. Epub 2025 Jun 3.
3
Isolation and molecular characterization of bacteriophages isolated from lake water and their application in foods against Bacillus cereus.
从湖水中分离的噬菌体的分离、分子特征及其在食品中对抗蜡样芽孢杆菌的应用。
BMC Res Notes. 2025 Sep 2;18(1):364. doi: 10.1186/s13104-025-07436-4.
4
Isolation and characterization of a novel bacteriophage PUTH1 active against Pseudomonas aeruginosa.一种对铜绿假单胞菌具有活性的新型噬菌体PUTH1的分离与鉴定
Virol J. 2025 Jul 19;22(1):248. doi: 10.1186/s12985-025-02859-8.
5
Current Applications and the Future of Phage Therapy for Periprosthetic Joint Infections.噬菌体疗法在人工关节感染中的当前应用及未来发展
Antibiotics (Basel). 2025 Jun 6;14(6):581. doi: 10.3390/antibiotics14060581.
6
Isolation and characterization of a novel phage targeting Klebsiella pneumoniae K2 capsular type.一种靶向肺炎克雷伯菌K2荚膜型的新型噬菌体的分离与鉴定。
Braz J Microbiol. 2025 Jun 6. doi: 10.1007/s42770-025-01707-9.
7
Virological and Pharmaceutical Properties of Clinically Relevant Phages.临床相关噬菌体的病毒学和药学特性
Antibiotics (Basel). 2025 May 10;14(5):487. doi: 10.3390/antibiotics14050487.
8
Bacteriophages Improve the Effectiveness of Rhamnolipids in Combating the Biofilm of .噬菌体提高了鼠李糖脂对抗……生物膜的有效性。 (原文结尾处不完整,有信息缺失)
Molecules. 2025 Apr 15;30(8):1772. doi: 10.3390/molecules30081772.
9
Characterization of the novel cross-genus phage vB_SmaS_QH3 and evaluation of its antibacterial efficacy against .新型跨属噬菌体vB_SmaS_QH3的特性及其对……的抗菌效果评估
Front Microbiol. 2025 Apr 11;16:1570665. doi: 10.3389/fmicb.2025.1570665. eCollection 2025.
10
Isolation, characterization, and application of the novel polyvalent bacteriophage vB_EcoM_XAM237 against pathogenic Escherichia coli.新型多价噬菌体vB_EcoM_XAM237对致病性大肠杆菌的分离、特性鉴定及应用
Vet Res. 2025 Apr 24;56(1):90. doi: 10.1186/s13567-025-01514-y.